IRIDEX to Report Second Quarter 2020 Financial Results on August 6, 2020
IRIDEX Corporation (Nasdaq: IRIX) will announce its second quarter 2020 financial results after trading on August 6, 2020. Management will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET, with dial-in options for domestic (844-707-0665) and international callers (703-326-3030), using conference ID: 6486158. A live and archived webcast will be available on the company’s website. IRIDEX specializes in laser-based medical systems for ophthalmology, utilizing its MicroPulse® technology to address conditions like glaucoma and diabetic macular edema.
- None.
- None.
MOUNTAIN VIEW, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2020 after the close of trading on Thursday, August 6, 2020. The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 6486158. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at: www.iridex.com.
About IRIDEX
IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the IRIDEX website at www.iridex.com.
Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investors@iridex.com
Media Contact:
Jamie Hall
Pascale Communications, LLC.
(724) 417-0167
pr@iridex.com
FAQ
When will IRIDEX Corporation announce its Q2 2020 financial results?
What time is the conference call for IRIDEX's Q2 2020 financial results?
How can investors access the conference call for IRIDEX Corporation?
Where can I find the archived webcast of the IRIDEX conference call?
